Brief: Advaxis Inc Announces Submission Of IND Application For ADXS-HOT Drug Candidate For Prostate Cancer
03/12/2019 14:10
Dec 3 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES SUBMISSION OF IND APPLICATION FOR
ADXS-HOT
DRUG CANDIDATE FOR PROSTATE CANCER
* ADVAXIS INC - IMMUNE RESPONSE DATA FROM ITS HOT LUNG
PROGRAM
EXPECTED EARLY 2020
Source text for Eikon: ID:nBw6w33Pja
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors